Inhibitors of apoptosis proteins in human cervical cancer

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Espinosa, Magali ^a   Cantú, David ^a   Herrera, Norma ^b   Lopez, Carlos M ^a   De la Garza, Jaime G ^a   Maldonado, Vilma ^a   Melendez Zajgla, Jorge ^a,c  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; ISOPROTEIN; MESSENGER RNA; PROTEIN C IAP1; PROTEIN C IAP2; SURVIVIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN; XIAP PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; CANCER RELAPSE; CANCER STAGING; CORRELATION ANALYSIS; DOWN REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KRUSKAL WALLIS TEST; LOG RANK TEST; MENOPAUSE; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS EPITHELIUM; STATISTICAL SIGNIFICANCE; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR; CHEMISTRY; FEMALE; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; CELL LINE, TUMOR; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 33645027387     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-45     Document Type: Article

References (36)

1. Deveraux QL, Takahashi R, Salvesen GS, Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388:300-304.
2. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV: The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995, 83:1243-1252.
3. Deveraux QL, Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 1999, 13:239-252.,
4. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997, 3:917-921.
5. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998,396:580-584.
6. Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K, Nakano T, Miura M, Shiraki K: Survivin initiates procaspase 3/p2l complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 2000, 19:1346-1353.
7. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB, Liu S: Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 2002, 21:2613-2622.
8. Zaffaroni N, Pennati M, Colella G, Perego P, Supino R, Gatti L, Pilotti S, Zunino F, Daidone MG: Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol Life Sci 2002, 59:1406-1412.
9. Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD: Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 1999, 59:6097-6102.
10. Schimmer AD: Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004, 64:7183-7190.
11. Holcik M, Gibson H, Korneluk RG: XIAP: apoptotic brake and promising therapeutic target. Apoptosis 2001, 6:253-261.
12. Bandala E, Espinosa M, Maldonado V, Melendez-Zajgla J: Inhibitor of apoptosis-I (IAP-I) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem Pharmacol 2001, 62:13-19.
13. Yamada Y, Kuroiwa T, Nakagawa T, Kajimoto Y, Dohi T, Azuma H, Tsuji M, Kami K, Miyatake S: Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg 2003, 99:738-745.
14. Yang L, Cao Z, Yan H, Wood WC: Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003, 63:6815-6824.
15. Nachmias B, Ashhab Y, Ben-Yehuda D: The inhibitor of apoptosis protein family (IAIPs): an emerging therapeutic target in cancer. Semin Cancer Biol 2004, 14:231-243.
16. Liu SS, Tsang BK, Cheung AN, Xue WC, Cheng DK, Ng TY, Wong LC, Ngan HY: Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer 2001, 37:1104-1110.
17. Samuel T, Okada K, Hyer M, Welsh K, Zapata JM, Reed JC: cIAPI Localizes to the nuclear compartment and modulates the cell cycle. Cancer Res 2005, 65:210-218.
18. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB: Characterization of XIAP-deficient mice. Mol Cell Biol 2001, 21:3604-3608.
19. Richmond A: Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2002, 2:664-674.
20. Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin ASJ: Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 2000, 19:1123-1131.
21. Holcik M, Gordon BW, Korneluk RG: The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2. Mol Cell Biol 2003, 23:280-288.
22. Altieri DC, Marchisio PC: Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 1999, 79:1327-1333.
23. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998, 58:5071-5074.
24. Kim HS, Shiraki K, Park SH: Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 2002, 22:805-808.
25. Lee JP, Chang KH, Han JH, Ryu HS: Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors. Int J Gynecol Cancer 2005, 15:113-119.
26. Kennedy SM, O'Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD, O'Higgins NJ, Parkinson M, Linehan R, Clynes M: Prognostic importance of survivin in breast cancer. Br J Cancer 2003, 88:1077-1083.
27. Nakanishi K, Tominaga S, Hiroi S, Kawai T, Aida S, Kasamatsu H, Aurues T, Hayashi T, Ikeda T: Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper unary tract. Virchows Arch 2002, 441:559-563.
28. Kjaer SK, Brinton LA: Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 1993, 15:486-498.
29. Ryan B, O'Donovan N, Browne B, O'Shea C, Crown J, Hill AD, McDermott E, O'Higgins N, Duffy MJ: Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer. Br J Cancer 2005,92:120-124.
30. Meng H, Lu C, Mabuchi H, Tanigawa N: Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Lett 2004, 216:147-155.
31. Yoshida H, Sumi T, Hyun Y, Nakagawa E, Hattori K, Yasui T, Morimura. M, Honda K, Nakatani T, Ishiko O: Expression of survivin and matrix metalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Oncol Rep 2003, 10:45-49.
32. Cao, C, Mu Y, Hallahan DE, Lu B: XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene 2004, 23:7047-7052.
33. Uchida H, Tanaka T, Sasaki K, Kato K, Dehari H, Ito Y, Kobune M, Miyagishi M, Taira K, Tahara H, Hamada H: Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther 2004, 10:162-171.
34. McEleny K, Coffey R, Morrissey C, Williamson K, Zangemeister-Wittke U, Fitzpatrick JM, Watson RW. An antisense oligonucleotide to cIAP-I sensitizes prostate cancer cells to fas and TNFalpha mediated apoptosis. Prostate 2004, 59:419-425.
35. Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG, Meli M, Dohi T, Fortugno P, Nefedova Y, Gabrilovich DI, Colombo G, Altieri DC: Rational design of shepherdin, a novel anticancer agent. Cancer Cell 2005, 7:457-468.
36. Idenoue S, Hirohashi Y, Torigoe T, Sato Y, Tamura Y, Hariu H, Yamamoto M, Kurotaki T, Tsuruma T, Asanuma H, Kanaseki T, Ikeda H, Kashiwagi K, Okazaki M, Sasaki K, Sato T, Ohmura T, Hata F, Yamaguchi K, Hirata K, Sato N: A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Clin Cancer Res 2005, 11:1474-1482.